"iDoctor – Medical Blog"

WHEELING, W.Va. (MedPage Today) — Studies of cancer drugs that are expected to find survival advantages of two months or less should be undertaken only if the treatment costs less than $20,000, two NIH researchers recommended.

This entry was posted on Tuesday, June 30th, 2009 at 3:14 am and is filed under Health news. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.